6 research outputs found

    λ¬΄μ¦μƒμ˜ ν•œκ΅­ μ—¬μ„±μ—μ„œ κ³ μš”μ‚°ν˜ˆμ¦μ΄ ν˜ˆκ΄€ 경직도에 λ―ΈμΉ˜λŠ” 영ν–₯

    Get PDF
    μ˜κ³ΌλŒ€ν•™/석사Purpose Increased serum uric acid is a known risk factor for cardiovascular disease. Brachial-ankle pulse wave velocity (baPWV) is a simple index of arterial stiffness, while the coronary artery calcium score (CACS) derived from multidetector computed tomography is a good marker of coronary atherosclerosis. Patients with coronary artery stenosis have significantly elevated baPWV values. Therefore, we investigated the relationship between serum uric acid level and baPWV in asymptomatic subjects, taking into account confounding factors, including CACS. Materials and Methods Of 4894 patients who underwent baPWV measurement and coronary computed tomography angiography as part of a general health examination at Gangnam Severance Hospital from July 2006 through September 2013, 2720 healthy subjects were enrolled in this evaluation after exclusion of confounding factors. Serum uric acid level was divided into quartiles for men and women separately: men, Q1: 1.9-5.2, Q2: 5.21-5.9, Q3: 5.91-6.7, Q4: 6.71-12.1 mg/dL; women, Q1: 2.0-3.8, Q2: 3.81-4.3, Q3: 4.31-4.9, Q4: 4.91-8.7 mg/dL. High baPWV was defined as β‰₯1400 cm/s. Results The mean concentration of serum uric acid was found to be significantly lower in women than in men (4.37Β±0.91 vs. 5.94Β±1.15 mg/dL, p50 years), the highest quartile of serum uric acid was associated with high baPWV, after adjustments for other risk factors (OR compared with lowest quartile=1.806, 95% CI=1.065-3.063; p=0.028). Conclusion Serum uric acid is associated with aggravation of arterial stiffness in healthy Korean women, but not in men.ope

    Treatment of a Patient with Kaposi’s Sarcoma Arising during Hemodialysis with the Multikinase Inhibitor Pazopanib

    Get PDF
    Kaposi’s sarcoma (KS) is an unusual multifocal neoplastic angioproliferative disorder. We herein report a case of classic KS that occurred in a patient receiving hemodialysis for 7 years. The patient had a history of chronic renal failure due to glomerulonephritis for 20 years. Multiple reddened violaceous patches, plaques, and nodules were found on the right knee. Biopsy revealed positivity for human herpesvirus 8 (KS-associated herpesvirus) consistent with KS. Pazopanib, a multitarget tyrosine kinase inhibitor, is an effective agent for treatment of advanced soft tissue sarcoma. The patient received pazopanib for 6 months investigate its effects on KS. The skin lesions and painful symptoms showed improvement. Further studies are required to determine the mechanism underlying the anticancer action of pazopanib and the pathogenesis of KS.ope

    Esophageal cancer in esophageal diverticula associated with achalasia

    Get PDF
    The simultaneous occurrence of achalasia and esophageal diverticula is rare. Here, we report the case of a 68-year-old man with multiple esophageal diverticula associated with achalasia who was later diagnosed with early esophageal cancer. He initially presented with dysphagia and dyspepsia, and injection of botulinum toxin to the lower esophageal sphincter relieved his symptoms. Five years later, however, the patient presented with worsening of symptoms, and esophagogastroduodenoscopy (EGD) was performed. The endoscopic findings showed multifocal lugol-voiding lesions identified as moderate dysplasia. We decided to use photodynamic therapy to treat the multifocal dysplastic lesions. At follow-up EGD 2 months after photodynamic therapy, more lugol-voiding lesions representing a squamous cell carcinoma in situ were found. The patient ultimately underwent surgery for the treatment of recurrent esophageal multifocal neoplasia. After a follow-up period of 3 years, the patient showed a good outcome without symptoms. To manage premalignant lesions such as achalasia with esophageal diverticula, clinicians should be cautious, but have an aggressive approach regarding endoscopic surveillance.ope

    Asymptomatic hyperuricemia is independently associated with coronary artery calcification in the absence of overt coronary artery disease: A single-center cross-sectional study

    Get PDF
    Recently, the pathogenic role of uric acid (UA) in both systemic metabolic and atherosclerotic diseases has been investigated. We sought to determine the independent correlation between serum UA levels and coronary artery calcification, as a marker of subclinical atherosclerosis. A total of 4188 individuals without prior coronary artery disease or urate-deposition disease were included. All of the participants underwent multidetector computed tomography (MDCT) for the evaluation of coronary artery calcification (CAC) during their health check-ups. The subjects were divided into thre groups according to CAC scores (group 1: 0; group 2: 1-299; group 3: β‰₯300). After controlling for other confounders, serum UA levels were found to be positively associated with increasing CAC scores (Pβ€Š=β€Š0.001). Adjusted mean serum UA levels in each CAC group were estimated to be 5.2β€ŠΒ±β€Š0.1β€Šmg/dL, 5.3β€ŠΒ±β€Š0.1β€Šmg/dL, and 5.6β€ŠΒ±β€Š0.2β€Šmg/dL from groups 1, 2, and 3, respectively. Subsequent subgroup analyses revealed that this positive association was only significant in participants who were male, relatively older, less overweight, and did not have diabetes mellitus (DM), hypertension, smoking history, or renal dysfunction. In conclusion, serum uric acid levels were independently associated with CAC score severity and this finding is particularly relevant to the subjects who were male, relatively older, less overweight (body mass indexβ€Š<β€Š25β€Škg/m), and without a history of DM, hypertension, smoking, or renal dysfunction.ope

    Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist's perspective.

    No full text
    PURPOSE: Dysmorphic red blood cells (dRBCs) are indicative of glomerular disease and considered a first step in evaluating microscopic hematuria (MH). The predominance of dRBCs does not preclude urological disease; however, some contemporary guidelines advise nephrological evaluation without further urological evaluation, in contrast to the American Urological Association guideline. We investigated the feasibility and safety of omitting urological evaluation in patients presenting with MH. METHODS: A retrospective analysis was performed on 411 consecutive patients who presented with MH between January 2012 and December 2014. MH was defined as β‰₯3 RBCs per high-power field. All patients received full urological and nephrological evaluations including history and physical assessment, renal function, urine cytology, %dRBC, cystoscopy, computed tomography (CT) imaging, and renal biopsy when indicated. RESULTS: The median %dRBC was higher in patients with glomerular disease than in those with urological disease (40.4 vs. 21.1 %; p < 0.001). Among patients exhibiting %dRBC β‰₯ 40, 33/97 (34.0 %) had urological and 28/97 (28.9 %) had glomerular diseases. Urological diseases included 9/33 (27.3 %) clinically meaningful malignancies and 17/33 (51.5 %) conditions requiring immediate treatment. The rate of malignancy was comparable between %dRBC groups (p = 0.087). Among patients with final diagnoses who exhibited %dRBC β‰₯ 40, 32/61 (52.5 %) treatment-requiring conditions would have been unrecognized had cystoscopy and/or CT not been performed. For predicting glomerular disease, the presence of proteinuria demonstrated higher AUC than %dRBC β‰₯ 40 (0.77 vs. 0.65; p < 0.001). CONCLUSIONS: Identification of %dRBC β‰₯ 40 had modest diagnostic value in identifying glomerular disease, and concomitant presence of proteinuria was more indicative of glomerular origin in patients presenting with MH. Urological evaluation should not be omitted in these patients considering the prevalence of treatment-requiring urological disease.restrictio

    Hyperuricemia and risk of increased arterial stiffness in healthy women based on health screening in Korean population.

    No full text
    Hyperuricemia is a risk factor for cardiovascular disease and is associated with increased arterial stiffness in high-risk populations. However, given the possible sex-related differences in the prevalence of hyperuricemia, the association between elevated serum uric acid (SUA) level and increased arterial stiffness has yielded conflicting results. We investigated the relationship between SUA and arterial stiffness in asymptomatic healthy subjects who underwent a health examination. Subjects who underwent a comprehensive health examination were enrolled. After exclusion of extensive confounding factors, 2,704 healthy subjects with coronary calcium score < 100 were evaluated in the final analysis. All subjects underwent brachial-ankle pulse wave velocity (baPWV) to detect arterial stiffness. The SUA was divided into quartiles for its association with arterial stiffness and was analyzed separately for men and women. The mean SUA level was significantly lower in women than in men. The baPWV was significantly elevated in subjects with the highest quartile of SUA in women, but not in men. After adjusting for age, smoking, systolic blood pressure, body mass index, estimated glomerular filtration rate, fasting plasma glucose, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, and coronary artery calcium score, the highest quartile of SUA in women was significantly associated with increased risk of high baPWV compared with the lowest quartile of SUA (OR = 1.7, p = 0.018), whereas in men, SUA level was not associated with high baPWV. Our study showed that elevated SUA is independently associated with increased baPWV in healthy Korean women, but not in men.ope
    corecore